PHARMACY

SPJ founder, publisher Gary Cohen passes away

BY David Salazar

ALEXANDRIA, Va. — Gary M. Cohen, founder and publisher of Specialty Pharma Journal,  has passed away, the publication announced Friday. Cohen founded the publication in 2010 and served as publisher until his unexpected death on Sept. 18. 

“It is with great sadness that we mourn the passing of Gary M. Cohen,” SPJ editor Nicole Watkins, Editor, Specialty Pharma Journal. “SPJ, and the pharmacy community as a whole, has lost an iconic leader and visionary. Cohen was a master of his craft. His passion and dedication to the Specialty Pharmacy industry was second to none, and his contributions will live on.”

Cohen had more than 30 years’ experience working in pharmacy- and specialty pharmacy-related organizations. He founded and served as CEO of pharmaceutical education and marketing company Pharmacy Power-Pak and was president of CEO of Synergy Healthcare Communications. Cohen also founded and served as CEO of the National Association of Specialty Pharmacy, and was the founder and executive director of the Specialty Pharmacy Certification Board (SPCB).

“We are saddened by the sudden passing of Gary Cohen,” SPCB president Ray Tancredi said. “Gary was a tireless proponent of specialty pharmacy education and certification. The Specialty Pharmacy Certification Board offers our condolences to Gary's family."

“Gary will be dearly missed. His energy and confidence in those around him was uplifting and encouraging. He had an ability to make every interaction meaningful,” Watkins said. “While Gary was a great leader and teacher, he was an even better friend. Our heart and prayers go out to his family and friends.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Bayer names longtime vet president of U.S. pharmaceuticals division

BY David Salazar

WHIPPANY, N.J. — Bayer HealthCare Pharmaceuticals’ U.S. division has a new president. The company announced Thursday that longtime Bayer veteran Habib Dable would be taking over as president its U.S. pharmaceutical business, reporting to Philip Blake, who is the head of region Americas for Bayer HealthCare Pharmaceuticals and heads up U.S. corporate functions for the company.

“Habib Dable is a highly respected leader at Bayer, and I'm thrilled to have someone with such a wealth of experience step in to lead the company's largest pharmaceuticals market worldwide,” Blake said. “Having spent more than two decades at Bayer in a range of key roles with increasing management responsibility, Habib will be a critical asset as we look to build on our positive momentum in the U.S. to create long-term growth.”

Dable began his career at Bayer in 1994 as a sales representative, a position from which he moved to several senior roles in Japan, Canada and the U.S. where he led global product launches, among other responsibilities. Since 2013, Dable had been Bayer HealthCare Pharmaceuticals’ global head of specialty medicine, where he oversaw oncology, ophthalmology, neurology and hematology. 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Tris Pharma launches its Tussionex generic

BY David Salazar

MONMOUTH JUNCTION, N.J. — Specialty pharmaceutical company Tris Pharma on Thursday announced that it had launched its generic version of Tussionex (hydrocodone polistirex and chlorpheniramine) extended-release suspension. 
 
The drug is indicated to treat cough and upper respiratory symptoms of allergies and colds, and will be available in 115- and 473-ml bottles.
 
Tris’ suspension uses its LiquiXR technology, which uses an aqueous base coating system to avoid toxic organic solvents. The generic will be marketed and distributed by the company’s generic business following the expiration of a distribution agreement with Par Pharmaceuticals, who had the rights to it starting in 2010. 
 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?